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Abstract 
 
The emergence and fast global spread of COVID-19 has presented one of the greatest 
public health challenges in modern times with no proven cure or vaccine. Africa is still 
early in this epidemic, therefore the extent of disease severity is not yet clear. We used 
a mathematical model to fit to the observed cases of COVID-19 in South Africa to 
estimate the basic reproductive number and critical vaccination coverage to control 
the disease for different hypothetical vaccine efficacy scenarios. We also estimated 
the percentage reduction in effective contacts due to the social distancing measures 
implemented.  Early model estimates show that COVID-19 outbreak in South Africa 
had a basic reproductive number of 2.95 (95% credible interval [CrI] 2.83-3.33). A 
vaccine with 70% efficacy had the capacity to contain COVID-19 outbreak but at very 
higher vaccination coverage 94.44% (95% Crl 92.44-99.92%) with a vaccine of 100% 
efficacy requiring 66.10% (95% Crl 64.72-69.95%) coverage. Social distancing 
measures put in place have so far reduced the number of social contacts by 80.31% 
(95% Crl 79.76-80.85%). These findings suggest that a highly efficacious vaccine 
would have been required to contain COVID-19 in South Africa. Therefore, the current 
social distancing measures to reduce contacts will remain key in controlling the infec-
tion in the absence of vaccines and other therapeutics.   
 
 
 
 
 
 
 
 
 
 
Introduction 
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The Coronavirus Disease 2019 (COVID-19) originated in Wuhan, China, in December 
2019 and has rapidly spread around the world [1]. As this is a new and novel virus, 
there is a huge scientific evidence gap and therefore limited understanding of the ep-
idemiology of SARS-CoV-2, the pathogen that causes the disease COVID-19. Cur-
rently, the epicentre of the virus is in Europe and New York in the United States of 
America [2].  In Africa, the virus is just starting to set its foothold, with South Africa now 
reporting the majority of cases in the continent. The first case of the COVID-19 in 
South Africa was reported on the 5th of March 2020 [3]. Measures to contain the epi-
demic culminated in the declaration of the state of disaster leading to a national lock-
down on the 26th  of March 2020 with Gauteng, Western Cape, KwaZulu-Natal and the 
Free State provinces reporting most of the COVID-19 cases. The map in Fig 1 shows 
the distribution of COVID-19 confirmed cases in South Africa before the government 
mandated a lockdown. Gauteng province appeared to be the “epicentre” of COVID-19 
in South Africa for a number of reasons. First, the province has the largest population 
density [4, 5] and the urban population is poor with 20% of its population being food 
insecure [4]. Second, Gauteng province has two international airports including OR 
Tambo International Airport handling over 21 million passengers annually [6]. Third, 
the volume of people that use public transport runs into millions daily creating  social 
networks and patterns that are key in accelerating the spread of the disease. Finally, 
the province is the country’s economic hub, and many people (including international 
visitors) travel in and out of the province daily [4]. With the majority of confirmed cases 
early in the outbreak having been linked to international travel [7], it is not surprising 
that the most affected provinces (Gauteng, Western Cape and KwaZulu-Natal) have 
international airports with direct flights to affected global regions (Fig 1). The cases in 
the Free State province have mainly been attributed to a cluster transmission resulting 
from a mega church gathering [8]. 
Fig 1: COVID-19 cases distribution in South Africa by 27 March 2020.  Map was cre-
ated using ArcGIS® by ESRI version 10.5 (http://www.esri.com). 
 
With COVID-19 having been declared a global pandemic [9] and the urgent need to 
have an effective vaccine to control the pandemic [10], there is a need to understand 
the utility of mass vaccination campaigns for this pandemic. Critical in the early 
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stages of the disease is the need to clearly understand the spectrum of disease se-
verity and transmission characteristics of the disease in order to identify optimal con-
trol measures. Many of the control measures suggested for this pandemic have been 
attributed to the lessons learnt in Wuhan, China [11]. The challenges associated with 
real-time analysis of an evolving epidemic are well articulated in [12]. These include 
testing capacity and delayed appearance of symptoms and asymptomatic carriage. 
The impact of COVID-19 on South Africa may differ from that on China and other re-
gions such as Europe and North America.  South Africa has unique circumstances, 
for example, it has the highest numbers of people living with HIV, with a significant 
proportion not on treatment, and one of the largest tuberculosis (TB) burdens in the 
world [13, 14]. Moreover, underlining disease conditions such as diabetes, hyperten-
sion and chronic obstructive pulmonary disease are prevalent in South African and 
these are known to be risk factors for COVID-19 infection and mortality [15]. The age 
distribution for South Africa is also different from China and Europe as its young pop-
ulation accounts for the majority of the population [16]. 
Data from China and other settings have shown that SARS-CoV-2 is more infectious 
than influenza, and has an incubation period of about 5 days (median time) and a 
doubling time of 3 days [17, 18]. However, we have a limited understanding of the 
infectiousness of the virus in settings with different populations and a huge burden of 
other chronic conditions such as Africa. Mathematical models provide important in-
sights in the understanding of emerging infectious diseases and informing public 
health policies. Several mathematical models have been used to understand COVID-
19 transmission dynamics and inform public health policy [12, 19, 20, 21, 22] . The 
reproductive numbers of the COVID-19 epidemic in China have been determined in 
several modelling studies (Table 1).  
Here, we adapt a susceptible-exposed-infected-removed (SEIR) compartmental 
model to quantify early transmissibility of COVID-19 in South Africa and explore the 
potential utility of a vaccine in containing the disease.  The SEIR model has been used 
to model respiratory infections including Middle East Respiratory Syndrome (MERS) 
[23, 24], COVID-19 in Wuhan China [11], influenza [25, 26]  and global tracking of 
COVID-19 [27]. In addition, we estimate the reduction in effective contacts after the 
implementation of the severe and extreme shutdown of the society, and this is critical 
in determining the impact of social distancing in the South African context. 
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Study Location Reproductive number estimate 
Wu et al [28] Wuhan  2.68 [2.47-2.86] 
Shen et al. [29] Hubei province   6.49 [6.31-6.66] 
Liu et al. [30] China and overseas  2.90 [ 2.32-3.63] 
Majumder and Mandl [31] Wuhan  2.55 [2.00-3.10] 
Read et al. [32] China  3.11 [2.39-4.13] 
Zhao et al. [33] China  2.24 [1.96-2.55] 
Qun et al. [34] China  2.2 [1.40-3.90] 
Tang et al. [35] China  6.47 [ 5.71-7.23] 
Imai et al. [36] Wuhan  2.5 [1.50-3.50] 
 
Table 1: COVID-19 reproductive numbers from modelling studies in China. 
 
Methods 
We use a standard deterministic compartmental SEIR model to simulate COVID-19 in 
South Africa. The model classifies the human population into four epidemiological 
compartments at any time 𝑡𝑡, the susceptible 𝑆𝑆(𝑡𝑡),  exposed 𝐸𝐸(𝑡𝑡), infected 𝐼𝐼(𝑡𝑡) and the 
recovered 𝑅𝑅(𝑡𝑡).  The total population is thus given by  𝑁𝑁(𝑡𝑡) = 𝑆𝑆(𝑡𝑡) + 𝐸𝐸(𝑡𝑡) + 𝐼𝐼(𝑡𝑡) + 𝑅𝑅(𝑡𝑡).   
Susceptible individuals are infected upon interaction with infectious COVID-19 individ-
uals and the rate of daily generation of newly infected cases is given by 𝜆𝜆(𝑡𝑡) =
𝛽𝛽𝑆𝑆(𝑡𝑡)𝐼𝐼(𝑡𝑡)/𝑁𝑁, where the parameter 𝛽𝛽  is the effective contact rate, i.e. the contact that 
will result in an infection. The lockdown effect is modelled with parameter, 𝜖𝜖 ∈ (0,1) 
where 𝜖𝜖 ≃ 0  implies an ineffective lockdown and 𝜖𝜖 ≃ 1  implies a completely effective 
lockdown. The effective contact reduction term multiplies the effective contact rate in 
the model to give (1 − 𝜖𝜖)𝛽𝛽. Exposed individuals in the 𝐸𝐸(𝑡𝑡) compartment become in-
fectious at a constant rate 𝜎𝜎  and move to the 𝐼𝐼(𝑡𝑡) class. Infected individuals 𝐼𝐼(𝑡𝑡), 
recover at a constant rate 𝛾𝛾 to the removed class 𝑅𝑅(𝑡𝑡). The schematic model flow 
diagram is presented in S1 Fig. The model assumptions result in the following system 
of differential equations. 
𝑑𝑑𝑆𝑆
𝑑𝑑𝑡𝑡
= −(1 − 𝜖𝜖)𝛽𝛽𝑆𝑆𝐼𝐼
𝑁𝑁
  ,   𝑑𝑑𝐸𝐸
𝑑𝑑𝑡𝑡
= (1 − 𝜖𝜖)𝛽𝛽𝑆𝑆𝐼𝐼
𝑁𝑁
− 𝜎𝜎𝐸𝐸,    𝑑𝑑𝐼𝐼
𝑑𝑑𝑡𝑡
= 𝜎𝜎𝐸𝐸 − 𝛾𝛾𝐼𝐼,   𝑑𝑑𝑅𝑅
𝑑𝑑𝑡𝑡
= 𝛾𝛾𝐼𝐼.      (1)      
Following a similar approach in [37], we use a Markov Chain Monte Carlo (MCMC) 
within a Bayesian framework (in R FME package [38]) to fit the model to the cumulative 
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data of confirmed COVID-19 cases in South Africa and estimate the magnitude of the 
epidemic using the basic reproductive number and quantify required vaccines’ attrib-
utes to stem similar outbreaks. We used data on COVID-19 cases published by the 
South African Department of Health from the 5th of March 2020 to 28 March 2020 prior 
to the lockdown to estimate the basic reproductive number [39].  We set the model 
lockdown effect parameter 𝜖𝜖 = 0 when estimating the basic reproductive number. The 
percentage reduction in effective contacts after the lockdown 𝜖𝜖 was estimated by fitting 
the model to cumulative COVID-19 cases reported a week after the lockdown (from 
29th March to 11th April 2020).  Cumulative data for COVID- 19 cases reported in South 
Africa from the 5th March to 11th April 2020 is shown in S1 Table. 
In the fitting, we set the lockdown effect parameter 𝜖𝜖 = 0  and varied 𝛽𝛽, 𝜎𝜎, 𝛾𝛾 (within 
parameter ranges in S2 Table) and initial infected population in order to estimate the 
basic reproductive number. In estimating the lockdown effect, we varied 𝜖𝜖 and kept 
parameters used to estimate the basic reproductive number constant. Gaussian like-
lihood was used to draw model parameter posteriors assuming uniform non-informa-
tive priors while the variances were regarded as nuisance parameters. The MCMC 
chain was generated with at least 100 000 runs for the final fitting excluding the burn-
in period. Chain convergence was examined visually and using the Coda R package 
[40]. Uncertainty of each estimated parameter was evaluated by analysing the MCMC 
chains and calculating the 2.5% and 97.5% quantiles to give the 95% credible interval 
(CrI).   
The basic reproductive number (ℛ0), is as a measure of the average number of second-
ary cases generated by a primary case and is an important statistic for quantifying inter-
vention programmes [41, 42]. Using an intuitive mathematical approach, the reproduc-
tive number of model system (1) is given by  ℛ0 = β/γ.  The corresponding minimum 
vaccination coverage (𝑐𝑐) for COVID-19 vaccine for different vaccine efficacy scenarios 
was estimated using the mathematical expression c ≥ (1-ℛ0−1)/s  where 𝑠𝑠 the propor-
tional reduction of the susceptibility for individuals partially immunized.  
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Results 
Estimates of effective contact rate (𝛽𝛽), the incubation period (1/𝜎𝜎), infectious period 
(1/𝛾𝛾), the percentage reduction in effective contacts (ϵ) and the basic reproductive 
number, ℛ0 for South Africa are shown in Table 2.  The mathematical model (of the 
SEIR type) was fitted to the cumulative COVID-19 cases for South Africa at the na-
tional level (Fig 2 (a)). We estimated an effective contact rate 1.30 (95% Crl 1.21-
1.39) per day, incubation period of 3.21 days (95% Crl 3.04-3.44 days), infectious 
period of 2.27 days (95% Crl 2.04-2.74 days) and  ℛ0 of  2.95 (95% Crl 2.83-3.33) 
before the lockdown.  The result ℛ0 >1 clearly shows disease sustainability in the 
country.  
 
 
 
 
 
 
 
Table 2: Estimates of effective contact rate (𝛽𝛽), the incubation period (1/𝜎𝜎), infec-
tious period (1/𝛾𝛾 ), the percentage reduction in effective contacts (ϵ) and basic repro-
ductive number (ℛ0). 
 
Fig 2: (a) Shows COVID-19 model fitting to cumulative cases where the green re-
gion is the 95% CrIs, the dashed brown line is the best model fit and the blue circles 
are the reported data for the cumulative number of COVID-19 cases in South Africa.  
(b) Shows the sensitivity analysis plot showing different vaccination coverages for 
different COVID-19 vaccine efficacy for South Africa. The dark grey regions are the 
95% CrIs and the black line is the median. 
 
Estimates of ℛ0 were used to conduct sensitivity analysis based on different COVID-
19 vaccines’ efficacy assumptions to explore possible scenarios that may arise from 
mass vaccination campaigns, as scientists attempt to develop effective vaccines for 
COVID-19 [43, 44] . The vaccine efficacy scenarios were assumed to vary in the range 
of 50-100% (Fig 2(b)). The results suggest that a vaccine with more than 70% efficacy 
Parameter description Estimated values [95 % Crls] 
Before lockdown  
Effective contact rate (𝛽𝛽)  1.30 [1.21-1.39] day-1 
Incubation period (1/𝜎𝜎) 3.21 [3.04-3.44] days 
Infectious period (1/𝛾𝛾 ) 2.27 [2.04-2.74] days 
Basic reproductive number (ℛ0) 2.95 [2.83-3.33]  
After lockdown  
Percentage reduction in effective contacts 
(𝜖𝜖) 
80.31 [79.76-80.85]% 
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could have the potential to contain the COVID-19 outbreak in South Africa but at ex-
tremely high vaccination coverage rates of 94.44% (95% Crl 92.44-99.92%). As ex-
pected, vaccination coverage for epidemic control decreases with an increase in vac-
cine efficacy, with a vaccine of 100% efficacy requiring 66.10% (95% Crl 64.71-
69.95%) coverage which is achievable under routine immunisation campaigns [45].   
 
We also quantified the percentage reduction in effective contacts as a result of the 
lockdown mandated by the government of South Africa.  Fig 3 shows that the epidemic 
is slowing down after the implementation of a lockdown. The results showed that the 
lockdown resulted in 80.31% (95% Crl 79.76-80.85%) reduction in effective contacts 
(Table 2) and consequently resulted in a reduction in the number of COVID-19 cases 
reported in the first two weeks of implementation. This confirms results in China that 
demonstrated the importance of quarantine, social distancing, and isolation in contain-
ing the pandemic [46] .  
 
Fig 3: The graph shows COVID-19 model fitting to cumulative cases where the 
green region is  the 95% CrIs, the dashed brown line is the best model fit and the 
blue circles mark are the reported data for the cumulative number of COVID-19 
cases in South Africa.  The red vertical line denotes the time when the lockdown was 
implemented by the government. The dark green region show the trajectory the epi-
demic would have taken if a lockdown was not implemented and the light green re-
gion show the trajectory of the epidemic after the implementation of a lockdown.  
 
Discussion 
COVID-19 has spread rapidly globally assisted by air travel in an increasingly con-
nected world [47, 48]. Globally most countries, including South Africa, have adopted 
one form or another of the lockdown approaches in an attempt to curb disease trans-
mission within their borders [11, 49, 50]. Our model estimate of  ℛ0>1 confirms COVID-
19 persistence in South Africa and indicate that the outbreak has the momentum to 
rapidly spread and spill over to other geographic regions of the country, in particular if 
the coming winter season (May to July) presents ideal environmental conditions for 
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persistence of the virus. The estimate of  ℛ0  for South Africa is in a similar range 
published for COVID-19 in other modelling studies (Table 1).  
Hypothetical scenarios on vaccine efficacy demonstrated that, a vaccine of at least 
70% efficacy would have been sufficient to contain the spread of COVID-19 in South 
Africa although at high vaccination coverage. However, it is important to note that ex-
pectations that the development of a highly effective vaccine for the novel-coronavirus 
will be achieved in the coming months are extremely optimistic, especially when con-
sidering that a vaccine has still not been successfully created for viruses like HIV, 
severe acute respiratory syndrome (SARS) and MERS, with the HIV vaccine 
being in development for many years [44, 51]. Nevertheless, the huge global interest 
in quickly identifying an effective vaccine could increase the possibility that a success-
ful vaccine candidate can be developed in the coming months [43]. Even when a safe 
and effective vaccine becomes available, there are several logistical and operational 
challenges that need to be addressed for successful deployment and for the vaccine 
to achieve the desired coverage [52, 53].  
The modelled lockdown demonstrated 80.31% reduction in effective contacts, show-
ing that it is an effective measure to bring the disease under control. However, the 
reduction in the number of daily reported cases should be interpreted with caution as 
this could also have been a result of many other factors such as reduced international 
travel to high-risk regions and behaviour change. As the epidemic continues to unfold, 
it remains to be seen what trend the epidemic will follow if local transmissions are 
sustained within South Africa. The implementation of this society shut down is not 
sustainable in the long run as it isunlikely to be tolerated for too long by the population. 
A vaccine would be an ideal preventative strategy for COVID-19 but it   appears that 
it should be complemented with prevention approaches such as isolation, quarantine, 
personal hygiene and limitations of public gatherings in order to achieve optimal pro-
tection of the population in South Africa.   
The economic and social burden of the disease continues to be felt and this likely to 
be enhanced by an extension of the current lockdown of 21 days by a further 2 weeks 
[54]. However it is unclear whether a stringent lockdown could be maintained for a 
longer period given the socio-economic challenges of the country where a significant 
percent of adults are involved in informal employment and others have jobs that do 
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not allow them to work from home. This could affect the effectiveness of the lockdown 
in many of the townships as individuals will have to ease lockdown conditions in order 
to be economically active and prevent financial woes on individuals in urban commu-
nities. While the epidemic seems to have slowed down as a results of the lockdown 
(Fig 3), there is need for continued scientific investigation including explorations 
through mathematical models to monitor the trend with the aim of informing public 
health policy in the short-term.  
The study has some limitations. The estimate of the reproductive number is based on 
available data and this estimate could possibly change depending on the quality of the 
data from the start of the epidemic (with possible under-reporting of cases in the initial 
phases of the epidemic).  We note that spatial modelling mainly in the affected prov-
inces would have been ideal but we did not have good data on a finer resolution to 
effectively parameterise a spatial model but as the epidemic evolves, nascent data on 
local COVID-19 transmission in South Africa is becoming available. We used a simple 
mathematical model without other population demographics as these were not im-
portant for short-term prediction [55]  and such models are also important when epi-
demiological and clinical disease characteristics of the disease are not well estab-
lished as is the case for COVID-19 [56] .  The simple model is only intended to give 
preliminary estimates for an epidemic that is evolving and whose trend has the poten-
tial to change dramatically overtime. However, it would be interesting to see how our 
results will change when a more complicated model is used. Despite these shortfalls, 
findings in this study are important in understanding the transmissibility of the virus 
and informing the development of robust COVID-19 prevention and control pro-
grammes in South Africa and outlining mass vaccination expectations. 
The COVID-19 pandemic has continued to spread and causing many deaths than any 
infectious disease we have seen in recent years and this calls for an urgent and well-
coordinated timely and effective public health response. Currently there is no proven 
treatment or vaccines for COVID-19 and countries have embraced quarantine, social 
distancing, and isolation of infected individuals to contain the pandemic. Thus, as more 
setting-specific data about the transmission dynamics of the virus become available, 
the building of suitable mathematical models to weight out the impact of current public 
health control measures and explore the potential utility of anticipated biomedical in-
terventions such as vaccines is paramount. 
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Supporting information 
S1 Fig: Schematic COVID-19 model diagram outlining infection progression. The 
arrows connecting compartments denote COVID-19 infection at rate 𝛽𝛽𝑆𝑆(𝑡𝑡)𝐼𝐼(𝑡𝑡)/𝑁𝑁, pro-
gression to infectiousness 𝜎𝜎𝐸𝐸 and recovery rate 𝛾𝛾𝐼𝐼 respectively. 
 
 
Date Cumulative COVID-19 cases 
05 March 2020 1 
06 March 2020 1 
07 March 2020 2 
08 March 2020 3 
09 March 2020 6 
10 March 2020 9 
11 March 2020 13 
12 March 2020 16 
13 March 2020 24 
14 March 2020 38 
15 March 2020 51 
16 March 2020 62 
17 March 2020 85 
18 March 2020 116 
19 March 2020 150 
20 March 2020 202 
21 March 2020 240 
22 March 2020 274 
23 March 2020 402 
24 March 2020 554 
25 March 2020 709 
26 March 2020 927 
28 March 2020 1187 
29 March 2020 1280 
30 March 2020 1326 
31 March 2020 1353 
01 April 2020 1380 
02 April 2020 1462 
03 April 2020 1505 
04 April 2020 1585 
05 April 2020 1655 
06 April 2020 1686 
07 April 2020 1749 
08 April 2020 1845 
09 April 2020 1934 
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10 April 2020 2003 
11 April 2020 2028 
 
S1 Table: Cumulative COVID-19 cases for South Africa. This data of cases re-
ported from the 5th March to 11th April 2020 data. 
 
 
 
 
S2 Table: COVID-19 model parameters and values. *We used population size for 
Gauteng, Western Cape, KwaZulu-Natal and Free State provinces in estimating na-
tional level estimates as these were the only provinces with COVID-19 cases in the 
early phases of the epidemic. Population estimates were based on the 2019 census 
[1]. 
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Parameter description Parameter symbol Range/value Reference 
*Population Size N 36 196 938 [1] 
Effective contact rate  𝛽𝛽 0-2  day-1 assumed 
Incubation period  1/𝜎𝜎 3-7 days [2] 
Infectious period 1/𝛾𝛾 2-5 days [3, 4] 
Percentage reduction in 
effective contacts  
𝜖𝜖 0-100% assumed 





